跳至主要内容
临床试验/IRCT20200317046797N7
IRCT20200317046797N7已完成2 期

Verification of the efficacy of bromhexine hydrochloride in the prevention of COVID-19 disease

Tabriz University of Medical Sciences0 个研究点目标入组 3,500 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
3,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • 18 Years to 80 years old
  • Both genders
  • Having household contact or contact in less than 1.5 meters for more than one hour, or exposed without facemask with a COVID-19 case confirmed with RT-PCR or with clinical or radiographic evidence of pneumonia, acute respiratory distress syndrome (ARDS)
  • Free of the COVID-19 disease symptoms (fever, cough, dyspnea, difficulty breathing, sore throat, severe fatigue, headache, GI symptoms)
  • Free from chronic respiratory or other illnesses with symptoms confused with symptoms of COVID-19 disease
  • Signed consent form

排除标准

  • Less than 18 years
  • Severe renal failure
  • Severe liver disease
  • Pregnant or breastfeeding woman or with a positive pregnancy test result
  • Subjects on immune-modulating drugs for other diseases
  • subjects on other clinical trials for COVID-19 within 30 days before or after randomization
  • Subjects in other drug clinical trial
  • Having an allergy to bromhexine hydrochloride or its ingredients

研究者

相似试验